T 0336/17 (Nanofiltration of factor VII solutions/NOVO NORDISK) of 18.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T033617.20210318
- Date of decision
- 18 March 2021
- Case number
- T 0336/17
- Petition for review of
- -
- Application number
- 04804635.3
- IPC class
- C07K 1/34
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Nanofiltration of factor VII solutions to remove virus
- Applicant name
- Novo Nordisk Health Care AG
- Opponent name
- Baxter International Inc.
Laboratoire Français du Fractionnement et des Biotechnologies - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)
- Keywords
- Amendments - added subject-matter (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.